HOME >> BIOLOGY >> NEWS
AACR Annual Meeting showcases significant developments in understanding and targeting cancers

LOS ANGELES -- Data demonstrating genetic differences in individuals susceptibility to certain cancers as well as differences in how people respond to specific cancer treatments will take center stage when more than 17,000 scientists from around the world gather at the Los Angeles Convention Center April 14-18 for the 2007 Annual Meeting of the American Association for Cancer Research (AACR). Key data presented at the meeting will also include findings related to the safety and effectiveness of several new, high-profile cancer therapies and vaccines.

"Because of significant diagnostic and therapeutic advances such as personalized and targeted therapies that prolong patients lives, the number of people successfully managing and living with cancer continues to grow," said Geoffrey M. Wahl, Ph.D., President, AACR. "By hosting the largest meeting in the world of its kind where the science behind these significant developments is shared and analyzed by researchers at the leading edge of cancer study the AACR promotes clinical exchange with the goal of ensuring research discoveries translate directly into improved patient outcomes."

The theme of this years annual meeting, "A Century of Leadership in Science A Future of Cancer Prevention and Cures," commemorates the AACRs Centennial and underscores the remarkable scientific advances that researchers have achieved in the 100 years since the organizations founding, well as the critical importance of ongoing research.

The opening Centennial Ceremony will set an exciting and inspirational tone for a week of science and discovery, with a procession of young researchers bearing flags of all 70 AACR member nations, appearances by the University of Southern California (USC) Marching Band, the All-American Boys Choir and presentation of Centennial Medals and other honors to leading cancer researchers and advocates.

The opening plenary, "Translating a Century of Science into a Futu
'"/>

Contact: Staci Vernick Goldberg
goldberg@aacr.org
267-646-0616
American Association for Cancer Research
10-Apr-2007


Page: 1 2 3

Related biology news :

1. NY Stem Cell Foundations 2nd Annual Translational Stem Cell Research Conference
2. Illinois researchers presenting at ASPB Annual Meeting in Chicago, July 7-11
3. Highlighted sessions of ASBMBs 2007 Annual Meeting
4. Award lectures for ASBMBs 2007 Annual Meeting
5. AACR to present distinguished public service awards at 2007 Annual Meeting
6. New investigators tie for award at the 2007 AIUM Annual Convention
7. Presidential Recognition Awards presented at the 2007 AIUM Annual Convention
8. Advances in personalized medicine on agenda for 54th Society of Nucelar Medicine Annual Meeting
9. AACRs Sixth Annual Landon Awards recognize Richard Kolodner, Douglas Lowy and John Schiller
10. International Society for Heart and Lung Transplantation 27th Annual Meeting and Scientific Sessions
11. Research and program highlights of the 2007 Annual Clinical Genetics Meeting, March 21-25, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: